Virtual Medicinal Product (VMP) - Tralokinumab 300mg/2ml solution for injection pre-filled disposable devices
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Tralokinumab 300mg/2ml solution for injection pre-filled disposable devices | Start Date 01-02-2024 | End Date |
| Abbreviated Name | Abbreviated Name Tralokinumab 300mg/2ml inj pre-filled disposable devices | Start Date 01-02-2024 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2
- UDFS UOM
- ml
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- D11AH07
- BNF Codes
-
- BNF code 13050300
| Code | Start Date | End Date |
|---|---|---|
| 42603211000001109 | 01-02-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Tralokinumab | Based on Ingredient Substance | 150 mg | 1 ml |
Name
Tralokinumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150
Strength and UOM (Dmr)
1
Parent Products
-
VTMTralokinumab
-
VMP(Current) Tralokinumab 300mg/2ml solution for ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 2 pre-filled disposable injection |